Acquiring Company
Precision BioLogic
Acquired Company
George King Bio-Medical
Dartmouth
Overland ParkManufacturingBiotechnologyHealth CareBiotechnologyHealth CareDescription
Precision BioLogic Inc. announces its strategic acquisition of George King Bio-Medical, Inc. The merger aims to enhance support for the bleeding disorders community, with both organizations continuing to operate under the Precision BioLogic leadership. This acquisition builds on a shared commitment to innovation and quality in hemostasis diagnostics.
Quick answer
Precision BioLogic is acquiring George King Bio-Medical, announced October 16, 2025. Precision BioLogic is based in Dartmouth, Nova Scotia, Canada.
- How much did Precision BioLogic pay for George King Bio-Medical?
- The deal value was not disclosed.
- What does Precision BioLogic do?
- Precision BioLogic Inc. develops, manufactures, and markets the CRYOcheck™ line of frozen products used by medical professionals around the globe to diagnose coagulation disorders.
- Where are Precision BioLogic and George King Bio-Medical based?
- Precision BioLogic is based in Dartmouth, Nova Scotia, Canada. George King Bio-Medical is based in Overland Park, Kansas, United States.
- Who are the decision-makers at Precision BioLogic?
- Fundz holds 1 contact at Precision BioLogic. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Manufacturing and Biotechnology
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Avanos Medical acquires Nexus Medical for growth (September 15, 2025)
- ClearPoint Neuro acquires IRRAS for $5 million, $5M (November 20, 2025)
- Crescita acquires assets from Laboratoire Provence-Canada (November 6, 2025)
- IBA acquires PhantomX to enhance AI quality assurance (November 3, 2025)
- Intertek acquires Suplilab in Costa Rica (November 3, 2025)
- AbbVie acquires Bretisilocin for mental health expansion (October 15, 2025)
Who to call at Precision BioLogic, and when
When Precision BioLogic changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Precision BioLogic raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Precision BioLogic, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Precision BioLogic. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Precision BioLogic makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired George King Bio-Medical?
George King Bio-Medical was acquired by Precision BioLogic, based in Dartmouth. The deal was reported on October 16, 2025. Precision BioLogic Inc. develops, manufactures, and markets the CRYOcheck™ line of frozen products used by medical professionals around the globe to diagnose coagulation disorders. Precision BioLogic is privately held and operates in Manufacturing.
When did Precision BioLogic acquire George King Bio-Medical?
Precision BioLogic's acquisition of George King Bio-Medical was reported on October 16, 2025. Precision BioLogic Inc. announces its strategic acquisition of George King Bio-Medical, Inc. The merger aims to enhance support for the bleeding disorders community, with both organizations continuing to operate under the Precision BioLogic leadership. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does George King Bio-Medical do?
George King Bio-Medical, Inc. was founded in 1973 and specializes in providing quality fresh frozen human plasmas for clinical laboratories. It is privately held, operating in Biotechnology, and is based in Overland Park.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.